---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-092780"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:42:21.010805+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Outset Medical Q2 revenue $27.4M (-24% YoY); FY2024 guidance cut to ~$110M from $145-153M

## Summary
- Product revenue fell to $19.2M; service revenue rose 21.5% to $8.2M.
- GAAP net loss $(0.66)/share; non-GAAP net loss $(0.47)/share.
- Total gross margin improved to 35.7% from 21.4% YoY; non-GAAP gross margin 37.3%.
- FY2024 revenue guidance revised to ~$110M (prior $145-153M); non-GAAP gross margin now low-to-mid 30%.
- New console placements below expectations; company taking steps to improve execution.

## SEC filing metadata
- accession: 0000950170-24-092780
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017024092780/0000950170-24-092780-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017024092780/om-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-092780
- JSON: https://secwatch.observer/filing/0000950170-24-092780.json
- Plain text: https://secwatch.observer/filing/0000950170-24-092780.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.